Clinical Trial Update: Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of mitoxantrone in patients with refractory neuromyelitis optica and related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica
• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Novantrone (mitoxantrone)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders | Phase 4 | Status: UNKNOWN